Annals of internal medicine
-
Hepatitis C virus (HCV) infection can be cured, and the United States has joined the World Health Organization in calling for HCV elimination by 2030. However, historically low uptake of HCV treatment among people who inject drugs (PWID) threatens HCV elimination and exacerbates social and racial health disparities. ⋯ National Institutes of Health.
-
Randomized Controlled Trial
Effect of Molnupiravir on Biomarkers, Respiratory Interventions, and Medical Services in COVID-19 : A Randomized, Placebo-Controlled Trial.
In the MOVe-OUT trial, molnupiravir showed a clinically meaningful reduction in the risk for hospitalization or death in adults with mild to moderate COVID-19 and risk factors for progression to severe disease. ⋯ Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc.
-
Comment Meta Analysis
In diabetes, some statins reduce non-HDL-C better than others vs. placebo.
Hodkinson A, Tsimpida D, Kontopantelis E, et al. Comparative effectiveness of statins on non-high density lipoprotein cholesterol in people with diabetes and at risk of cardiovascular disease: systematic review and network meta-analysis. BMJ. 2022;376:e067731. 35331984.
-
The physician gender wage gap may be due, in part, to productivity-based compensation models that undervalue female practice patterns. ⋯ None.
-
Comment Meta Analysis
In HF, SGLT2 inhibitors reduce HF hospitalizations at up to 2 y.
Zou X, Shi Q, Vandvik PO, et al. Sodium-glucose cotransporter-2 inhibitors in patients with heart failure: a systematic review and meta-analysis. Ann Intern Med. 2022;175:851-61. 35404670.